VYNE

VYNE Therapeutics Inc.

Healthcare · USD

Set alert

Price alert · VYNE

All alert types
28.56 USD 0.00 0.00%
As of Jul 27, 2026 Extended hours 0.65 -97.73%
Bid
0.64 × 2
Ask
0.66 × 1
23.37 Day range 28.72
1.57 52-week range 3.43
YTD
+4,824.14%
1 year
+1,662.96%
Open
25.50
Prev close
28.56
Mkt cap
37.91M
Vol
93.26K
Avg vol
87.38K
EPS
3.29
P/E
0.78
Div yield
0.00%
More statistics
Low
23.37
High
28.72
Forward P/E
-2.95
Beta
1.35
Short ratio
0.65
Inst. own
51.92%
Dividend
0.00
Ex-div date
Earnings
Aug 14, 2024
50-d avg
2.68
200-d avg
2.31
1y target
6.19

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for VYNE has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-227.16 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.9×
FY 2016: -44.5×FY 2017: -20.3×FY 2018: -1.7×FY 2019: -2.2×FY 2020: -0.8×FY 2021: -0.7×FY 2022: -0.3×FY 2023: -0.8×FY 2024: -3.6×FY 2025: -0.9×
FY 2016 5y median -0.8× FY 2025
P/S 43.5×
FY 2016: 928×FY 2017: 129×FY 2018: 8.4×FY 2019: 355×FY 2020: 9.8×FY 2021: 56.4×FY 2022: 18.0×FY 2023: 56.5×FY 2024: 285×FY 2025: 43.5×
FY 2016 5y median 56.4× FY 2025
P/B 0.9×
FY 2016: -21.2×FY 2017: -10.4×FY 2018: 0.7×FY 2019: 2.3×FY 2020: 5.5×FY 2021: 1.1×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 2.7×FY 2025: 0.9×
FY 2016 5y median 0.9× FY 2025
P/FCF -0.7×
FY 2016: -269×FY 2017: -20.9×FY 2018: -1.7×FY 2019: -2.4×FY 2020: -1.5×FY 2021: -0.9×FY 2022: -0.3×FY 2023: -0.9×FY 2024: -4.2×FY 2025: -0.7×
FY 2016 5y median -0.9× FY 2025
EV/EBITDA -0.0×
FY 2016: -43.4×FY 2017: -19.6×FY 2018: -0.7×FY 2019: -1.4×FY 2020: -0.7×FY 2021: -0.3×FY 2022: 0.7×FY 2023: 0.2×FY 2024: -3.1×FY 2025: -0.0×
FY 2016 5y median -0.0× FY 2025
EV/Sales 1.4×
FY 2016: 922×FY 2017: 127×FY 2018: 3.7×FY 2019: 288×FY 2020: 8.7×FY 2021: 11.4×FY 2022: -46.8×FY 2023: -15.3×FY 2024: 245×FY 2025: 1.4×
FY 2016 5y median 1.4× FY 2025
FCF Yield -133.5%
FY 2016: -0.4%FY 2017: -4.8%FY 2018: -59.2%FY 2019: -41.3%FY 2020: -67.0%FY 2021: -107.4%FY 2022: -339.5%FY 2023: -105.9%FY 2024: -23.9%FY 2025: -133.5%
FY 2016 5y median -107.4% FY 2025

Profitability

Gross Margin 96.0%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 21.0%FY 2020: 93.4%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 96.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -5219.1%
FY 2016: -2126.4%FY 2017: -645.9%FY 2018: -512.5%FY 2019: -17210.4%FY 2020: 1203.0%FY 2021: -4179.5%FY 2022: -7189.7%FY 2023: -6900.5%FY 2024: -8710.0%FY 2025: -5219.1%
FY 2016 5y median -6900.5% FY 2025
Net Margin -4646.1%
FY 2016: -2087.2%FY 2017: -634.6%FY 2018: -483.5%FY 2019: -15906.1%FY 2020: -1217.4%FY 2021: -7876.4%FY 2022: -4865.8%FY 2023: -6710.4%FY 2024: -7950.9%FY 2025: -4646.1%
FY 2016 5y median -6710.4% FY 2025
ROE -95.4%
FY 2016: 47.8%FY 2017: 51.0%FY 2018: -39.5%FY 2019: -102.9%FY 2020: -681.6%FY 2021: -150.8%FY 2022: -74.4%FY 2023: -32.1%FY 2024: -76.5%FY 2025: -95.4%
FY 2016 5y median -76.5% FY 2025
ROIC -107.1%
FY 2016: -37.6%FY 2017: -50.1%FY 2018: -41.8%FY 2019: -105.3%FY 2020: 346.9%FY 2021: -79.4%FY 2022: -109.2%FY 2023: -32.4%FY 2024: -83.6%FY 2025: -107.1%
FY 2016 5y median -83.6% FY 2025
ROA -87.8%
FY 2016: -33.5%FY 2017: -43.5%FY 2018: -36.8%FY 2019: -89.0%FY 2020: -272.6%FY 2021: -109.4%FY 2022: -56.9%FY 2023: -29.1%FY 2024: -59.5%FY 2025: -87.8%
FY 2016 5y median -59.5% FY 2025

Growth (YoY)

Revenue 13.8%
FY 2016: 0.0%FY 2017: 579.8%FY 2018: 132.2%FY 2019: -95.8%FY 2020: 4638.8%FY 2021: -95.6%FY 2022: -48.8%FY 2023: -11.1%FY 2024: 18.2%FY 2025: 13.8%
FY 2016 FY 2025
Operating Income 31.8%
FY 2016: -211.0%FY 2017: -106.5%FY 2018: -84.3%FY 2019: -39.8%FY 2020: 431.2%FY 2021: -115.4%FY 2022: 11.9%FY 2023: 14.7%FY 2024: -49.1%FY 2025: 31.8%
FY 2016 FY 2025
EPS (diluted) 34.0%
FY 2016: -61.7%FY 2017: -118.6%FY 2018: -68.2%FY 2019: 12.6%FY 2020: 5.1%FY 2021: 81.9%FY 2022: 58.5%FY 2023: 74.0%FY 2024: 66.1%FY 2025: 34.0%
FY 2016 FY 2025
Free Cash Flow 2.8%
FY 2016: 44.5%FY 2017: -1117.7%FY 2018: -87.0%FY 2019: -23.1%FY 2020: -110.7%FY 2021: 58.9%FY 2022: 48.2%FY 2023: 13.2%FY 2024: -34.5%FY 2025: 2.8%
FY 2016 FY 2025

Financial Health

Current Ratio 12.5×
FY 2016: 8.1×FY 2017: 8.2×FY 2018: 14.6×FY 2019: 7.3×FY 2020: 4.0×FY 2021: 3.4×FY 2022: 4.1×FY 2023: 12.7×FY 2024: 4.3×FY 2025: 12.5×
FY 2016 5y median 4.3× FY 2025
Quick Ratio 12.5×
FY 2016: 8.1×FY 2017: 8.6×FY 2018: 14.6×FY 2019: 7.3×FY 2020: 3.7×FY 2021: 3.0×FY 2022: 4.1×FY 2023: 12.7×FY 2024: 4.3×FY 2025: 12.5×
FY 2016 5y median 4.3× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.9×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.9×
FY 2016: 0.3×FY 2017: 0.3×FY 2018: 0.9×FY 2019: 0.3×FY 2020: 0.1×FY 2021: 1.1×FY 2022: 0.9×FY 2023: 1.1×FY 2024: 0.5×FY 2025: 0.9×
FY 2016 5y median 0.9× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -82.8×FY 2020: 57.5×FY 2021: -6.9×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31